Imagine
The potential of medical innovation is limitless. If Europe fully seizes this opportunity, just imagine what we could achieve
LEARN MOREHow can we ensure Europeans don't miss out on the latest advances in treatment?Â
EFPIA Code of Practice and relationships with patient organisations and healthcare professionals.
Latest Updates
VIEW ALL-
Blog articles 28.05.24
New data demonstrates the value of regulatory data protection (RDP), and its impact on European competitiveness...
EFPIA believes EU leaders’ focus on competitiveness is positive but more joined-up thinking is urgently needed to achieve open strategic autonomy
Read Article -
Statements & press releases 21.05.24
Pharmaceutical trade associations welcome latest announcement of largest number of regulatory agencies...
The WLA framework is crucial for regulatory convergence and harmonisation.
Read Article -
Blog articles 20.05.24
Lab of the future: when science and technology meet to deliver medicines faster in Europe (Guest blog)...
As science evolves, if you're just keeping up, you're already behind the curve.
Read Article -
Partner Event 31.05.24
IMI impact on antimicrobial resistance
Combatting antimicrobial resistance: the legacy of the IMI COMBACTE projects.
View Event -
EFPIA Event 04.06.24
Countdown to the EU HTA: how can we seize this opportunity to improve patient access to medicines?
In January 2025, all new cancer medicines and advanced therapy medicinal products (ATMPs) will be jointly assessed at the EU level.
View Event -
External Event 31.10.24
Executive MSc Healthcare Decision-Making at LSE
Discover the transformative Executive MSc in Healthcare Decision-Making, a dynamic partnership between NICE and LSE.
View Event
Featured Articles
